JOYCE BUMBALOUGH: Open Payments
NPI 1871961755 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 30 payments from 11 companies in 2025. Trend: 2023 $360 · 2024 $593 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $193 |
| ABBVIE INC. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Sage Therapeutics, LLC | 3 | $56 |
| Amgen Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Astellas Pharma US Inc | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
Products named: Ozempic, VRAYLAR, Wegovy, CAPLYTA, ZURZUVAE, OTEZLA, Rybelsus, Veozah.
Industry payments across TN — which companies pay providers there.
